APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

TIGIT Therapies

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global TIGIT Therapies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174041340330 December 2025195 pages

Choose your research edition.

Industry ResearchTIGIT Therapies Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal TIGIT Therapies Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal TIGIT Therapies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal TIGIT Therapies Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal TIGIT Therapies Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global TIGIT Therapies market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for TIGIT Therapies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for TIGIT Therapies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for TIGIT Therapies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for TIGIT Therapies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of TIGIT Therapies include Arcus, Astellas, BMS, Compugen, Mereo BioPharma, Seattle Genetics, AstraZeneca, BeiGene and Hengrui Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global TIGIT Therapies market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of TIGIT Therapies and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents TIGIT Therapies revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the TIGIT Therapies market size, projected growth trends, production technologies, key applications, and end-use industries.

TIGIT Therapies Segment by Company

Arcus

Astellas

BMS

Compugen

Mereo BioPharma

Seattle Genetics

AstraZeneca

BeiGene

Hengrui Medicine

Junshi Biosciences

Roche

Merck

Innovent Biologics

TIGIT Therapies Segment by Type

Monotherapy

Combination Therapy

TIGIT Therapies Segment by Application

Cell Carcinoma

Solid Tumor

TIGIT Therapies Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global TIGIT Therapies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of TIGIT Therapies and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of TIGIT Therapies.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of TIGIT Therapies in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global TIGIT Therapies industry.

Chapter 3: Detailed analysis of TIGIT Therapies companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, TIGIT Therapiesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global TIGIT Therapies Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Monotherapy Table 3. Key Players of Combination Therapy Table 4. Global TIGIT Therapies Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Cell Carcinoma Table 6. Key Players of Solid Tumor Table 7. Global TIGIT Therapies Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global TIGIT Therapies Market Size by Region (2021-2026) & (US$ Million) Table 9. Global TIGIT Therapies Market Share by Region (2021-2026) Table 10. Global TIGIT Therapies Market Size by Region (2027-2032) & (US$ Million) Table 11. Global TIGIT Therapies Market Share by Region (2027-2032) Table 12. TIGIT Therapies Industry Trends Table 13. TIGIT Therapies Industry Drivers Table 14. TIGIT Therapies Industry Opportunities and Challenges Table 15. TIGIT Therapies Industry Restraints Table 16. Global TIGIT Therapies Revenue by Company (US$ Million) & (2021-2026) Table 17. Global TIGIT Therapies Revenue Market Share by Company (2021-2026) Table 18. Global TIGIT Therapies Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global TIGIT Therapies Key Company Head Office and Area Served Table 20. Global TIGIT Therapies Company, Product Type & Application Table 21. Global TIGIT Therapies Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global TIGIT Therapies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global TIGIT Therapies Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global TIGIT Therapies Market Size by Type (2021-2026) & (US$ Million) Table 26. Global TIGIT Therapies Market Size by Type (2027-2032) & (US$ Million) Table 27. Global TIGIT Therapies Revenue Market Share by Type (2021-2026) Table 28. Global TIGIT Therapies Revenue Market Share by Type (2027-2032) Table 29. Global TIGIT Therapies Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global TIGIT Therapies Market Size by Application (2021-2026) & (US$ Million) Table 31. Global TIGIT Therapies Market Size by Application (2027-2032) & (US$ Million) Table 32. Global TIGIT Therapies Revenue Market Share by Application (2021-2026) Table 33. Global TIGIT Therapies Revenue Market Share by Application (2027-2032) Table 34. Arcus Company Information Table 35. Arcus Business Overview Table 36. Arcus TIGIT Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Arcus TIGIT Therapies Product Portfolio Table 38. Arcus Recent Development Table 39. Astellas Company Information Table 40. Astellas Business Overview Table 41. Astellas TIGIT Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Astellas TIGIT Therapies Product Portfolio Table 43. Astellas Recent Development Table 44. BMS Company Information Table 45. BMS Business Overview Table 46. BMS TIGIT Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. BMS TIGIT Therapies Product Portfolio Table 48. BMS Recent Development Table 49. Compugen Company Information Table 50. Compugen Business Overview Table 51. Compugen TIGIT Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Compugen TIGIT Therapies Product Portfolio Table 53. Compugen Recent Development Table 54. Mereo BioPharma Company Information Table 55. Mereo BioPharma Business Overview Table 56. Mereo BioPharma TIGIT Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Mereo BioPharma TIGIT Therapies Product Portfolio Table 58. Mereo BioPharma Recent Development Table 59. Seattle Genetics Company Information Table 60. Seattle Genetics Business Overview Table 61. Seattle Genetics TIGIT Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Seattle Genetics TIGIT Therapies Product Portfolio Table 63. Seattle Genetics Recent Development Table 64. AstraZeneca Company Information Table 65. AstraZeneca Business Overview Table 66. AstraZeneca TIGIT Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. AstraZeneca TIGIT Therapies Product Portfolio Table 68. AstraZeneca Recent Development Table 69. BeiGene Company Information Table 70. BeiGene Business Overview Table 71. BeiGene TIGIT Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. BeiGene TIGIT Therapies Product Portfolio Table 73. BeiGene Recent Development Table 74. Hengrui Medicine Company Information Table 75. Hengrui Medicine Business Overview Table 76. Hengrui Medicine TIGIT Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Hengrui Medicine TIGIT Therapies Product Portfolio Table 78. Hengrui Medicine Recent Development Table 79. Junshi Biosciences Company Information Table 80. Junshi Biosciences Business Overview Table 81. Junshi Biosciences TIGIT Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Junshi Biosciences TIGIT Therapies Product Portfolio Table 83. Junshi Biosciences Recent Development Table 84. Roche Company Information Table 85. Roche Business Overview Table 86. Roche TIGIT Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Roche TIGIT Therapies Product Portfolio Table 88. Roche Recent Development Table 89. Merck Company Information Table 90. Merck Business Overview Table 91. Merck TIGIT Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Merck TIGIT Therapies Product Portfolio Table 93. Merck Recent Development Table 94. Innovent Biologics Company Information Table 95. Innovent Biologics Business Overview Table 96. Innovent Biologics TIGIT Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Innovent Biologics TIGIT Therapies Product Portfolio Table 98. Innovent Biologics Recent Development Table 99. North America TIGIT Therapies Market Size by Type (2021-2026) & (US$ Million) Table 100. North America TIGIT Therapies Market Size by Type (2027-2032) & (US$ Million) Table 101. North America TIGIT Therapies Market Size by Application (2021-2026) & (US$ Million) Table 102. North America TIGIT Therapies Market Size by Application (2027-2032) & (US$ Million) Table 103. North America TIGIT Therapies Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. North America TIGIT Therapies Market Size by Country (2021-2026) Table 105. North America TIGIT Therapies Market Size by Country (2027-2032) Table 106. Europe TIGIT Therapies Market Size by Type (2021-2026) & (US$ Million) Table 107. Europe TIGIT Therapies Market Size by Type (2027-2032) & (US$ Million) Table 108. Europe TIGIT Therapies Market Size by Application (2021-2026) & (US$ Million) Table 109. Europe TIGIT Therapies Market Size by Application (2027-2032) & (US$ Million) Table 110. Europe TIGIT Therapies Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. Europe TIGIT Therapies Market Size by Country (2021-2026) Table 112. Europe TIGIT Therapies Market Size by Country (2027-2032) Table 113. China TIGIT Therapies Market Size by Type (2021-2026) & (US$ Million) Table 114. China TIGIT Therapies Market Size by Type (2027-2032) & (US$ Million) Table 115. China TIGIT Therapies Market Size by Application (2021-2026) & (US$ Million) Table 116. China TIGIT Therapies Market Size by Application (2027-2032) & (US$ Million) Table 117. Asia TIGIT Therapies Market Size by Type (2021-2026) & (US$ Million) Table 118. Asia TIGIT Therapies Market Size by Type (2027-2032) & (US$ Million) Table 119. Asia TIGIT Therapies Market Size by Application (2021-2026) & (US$ Million) Table 120. Asia TIGIT Therapies Market Size by Application (2027-2032) & (US$ Million) Table 121. Asia TIGIT Therapies Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Asia TIGIT Therapies Market Size by Country (2021-2026) Table 123. Asia TIGIT Therapies Market Size by Country (2027-2032) Table 124. South America, Middle East & Africa TIGIT Therapies Market Size by Type (2021-2026) & (US$ Million) Table 125. South America, Middle East & Africa TIGIT Therapies Market Size by Type (2027-2032) & (US$ Million) Table 126. South America, Middle East & Africa TIGIT Therapies Market Size by Application (2021-2026) & (US$ Million) Table 127. South America, Middle East & Africa TIGIT Therapies Market Size by Application (2027-2032) & (US$ Million) Table 128. South America, Middle East & Africa TIGIT Therapies Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. South America, Middle East & Africa TIGIT Therapies Market Size by Country (2021-2026) Table 130. South America, Middle East & Africa TIGIT Therapies Market Size by Country (2027-2032) Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. TIGIT Therapies Product Image Figure 2. Global TIGIT Therapies Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global TIGIT Therapies Market Share by Type: 2025 VS 2032 Figure 4. Monotherapy Image Figure 5. Combination Therapy Image Figure 6. Global TIGIT Therapies Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global TIGIT Therapies Market Share by Application: 2025 VS 2032 Figure 8. Cell Carcinoma Image Figure 9. Solid Tumor Image Figure 10. Global TIGIT Therapies Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 12. Global TIGIT Therapies Market Share by Region: 2025 VS 2032 Figure 13. Years Considered Figure 14. Global TIGIT Therapies Market Share by Players in 2025 Figure 15. Global Top 5 and 10 TIGIT Therapies Players Market Share by Revenue in 2025 Figure 16. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global TIGIT Therapies Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global TIGIT Therapies Revenue Market Share by Type (2021-2032) Figure 19. Global TIGIT Therapies Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global TIGIT Therapies Revenue Market Share by Application (2021-2032) Figure 21. North America TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 22. North America TIGIT Therapies Market Share by Type (2021-2032) Figure 23. North America TIGIT Therapies Market Share by Application (2021-2032) Figure 24. North America TIGIT Therapies Market Share by Country (2021-2032) Figure 25. United States TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 26. Canada TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 27. Mexico TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 28. Europe TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 29. Europe TIGIT Therapies Market Share by Type (2021-2032) Figure 30. Europe TIGIT Therapies Market Share by Application (2021-2032) Figure 31. Europe TIGIT Therapies Market Share by Country (2021-2032) Figure 32. Germany TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 33. France TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 34. U.K. TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 35. Italy TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 36. Russia TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 37. Nordic Countries TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 38. China TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 39. China TIGIT Therapies Market Share by Type (2021-2032) Figure 40. China TIGIT Therapies Market Share by Application (2021-2032) Figure 41. Asia TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 42. Asia TIGIT Therapies Market Share by Type (2021-2032) Figure 43. Asia TIGIT Therapies Market Share by Application (2021-2032) Figure 44. Asia TIGIT Therapies Market Share by Country (2021-2032) Figure 45. Japan TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 46. South Korea TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 47. Taiwan TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 48. Southeast Asia TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 49. India TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 50. Australia TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 51. South America, Middle East & Africa TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa TIGIT Therapies Market Share by Type (2021-2032) Figure 53. South America, Middle East & Africa TIGIT Therapies Market Share by Application (2021-2032) Figure 54. South America, Middle East & Africa TIGIT Therapies Market Share by Country (2021-2032) Figure 55. Brazil TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 56. South Africa TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 57. Saudi Arabia TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 58. Turkey TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 59. Argentina TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 60. UAE TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 61. Egypt TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 62. Chile TIGIT Therapies Market Size (2021-2032) & (US$ Million) Figure 63. Research Process Figure 64. Key Executives Interviewed

Scope & coverage.

Types
  • Monotherapy
  • Combination Therapy
Applications
  • Cell Carcinoma
  • Solid Tumor
Companies covered
  • Arcus
  • Astellas
  • BMS
  • Compugen
  • Mereo BioPharma
  • Seattle Genetics
  • AstraZeneca
  • BeiGene
  • Hengrui Medicine
  • Junshi Biosciences
  • Roche
  • Merck
  • Innovent Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global TIGIT Therapies Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Monotherapy
  5. 1.2.3 Combination Therapy
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global TIGIT Therapies Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Cell Carcinoma
  9. 1.3.3 Solid Tumor
  10. 1.4 Global Market Growth Prospects
  11. 1.5 Global TIGIT Therapies Growth Trends by Region
  12. 1.5.1 Global TIGIT Therapies Market Size by Region: 2021 VS 2025 VS 2032
  13. 1.5.2 TIGIT Therapies Market Size by Region (2021-2026)
  14. 1.5.3 TIGIT Therapies Market Size by Region (2027-2032)
  15. 1.6 Assumptions and Limitations
  16. 1.7 Study Goals and Objectives
  17. 1.8 Years Considered
2 Global TIGIT Therapies Market Dynamics
  1. 2.1 TIGIT Therapies Industry Trends
  2. 2.2 TIGIT Therapies Industry Drivers
  3. 2.3 TIGIT Therapies Industry Opportunities and Challenges
  4. 2.4 TIGIT Therapies Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global TIGIT Therapies Revenue by Company (2021-2026)
  2. 3.2 Global TIGIT Therapies Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global TIGIT Therapies Key Company Head office and Area Served
  4. 3.4 Global TIGIT Therapies Company, Product Type & Application
  5. 3.5 Global TIGIT Therapies Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global TIGIT Therapies Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 TIGIT Therapies Players Market Share by Revenue in 2025
  9. 3.6.3 2025 TIGIT Therapies Tier 1, Tier 2, and Tier 3
4 TIGIT Therapies Market by Type
  1. 4.1 Global TIGIT Therapies Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global TIGIT Therapies Market Size by Type (2021-2032)
  3. 4.3 Global TIGIT Therapies Market Size Share by Type (2021-2032)
5 TIGIT Therapies Market by Application
  1. 5.1 Global TIGIT Therapies Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global TIGIT Therapies Market Size by Application (2021-2032)
  3. 5.3 Global TIGIT Therapies Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Arcus
  2. 6.1.1 Arcus Company Information
  3. 6.1.2 Arcus Business Overview
  4. 6.1.3 Arcus TIGIT Therapies Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Arcus TIGIT Therapies Product Portfolio
  6. 6.1.5 Arcus Recent Developments
  7. 6.2 Astellas
  8. 6.2.1 Astellas Company Information
  9. 6.2.2 Astellas Business Overview
  10. 6.2.3 Astellas TIGIT Therapies Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Astellas TIGIT Therapies Product Portfolio
  12. 6.2.5 Astellas Recent Developments
  13. 6.3 BMS
  14. 6.3.1 BMS Company Information
  15. 6.3.2 BMS Business Overview
  16. 6.3.3 BMS TIGIT Therapies Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 BMS TIGIT Therapies Product Portfolio
  18. 6.3.5 BMS Recent Developments
  19. 6.4 Compugen
  20. 6.4.1 Compugen Company Information
  21. 6.4.2 Compugen Business Overview
  22. 6.4.3 Compugen TIGIT Therapies Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Compugen TIGIT Therapies Product Portfolio
  24. 6.4.5 Compugen Recent Developments
  25. 6.5 Mereo BioPharma
  26. 6.5.1 Mereo BioPharma Company Information
  27. 6.5.2 Mereo BioPharma Business Overview
  28. 6.5.3 Mereo BioPharma TIGIT Therapies Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Mereo BioPharma TIGIT Therapies Product Portfolio
  30. 6.5.5 Mereo BioPharma Recent Developments
  31. 6.6 Seattle Genetics
  32. 6.6.1 Seattle Genetics Company Information
  33. 6.6.2 Seattle Genetics Business Overview
  34. 6.6.3 Seattle Genetics TIGIT Therapies Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Seattle Genetics TIGIT Therapies Product Portfolio
  36. 6.6.5 Seattle Genetics Recent Developments
  37. 6.7 AstraZeneca
  38. 6.7.1 AstraZeneca Company Information
  39. 6.7.2 AstraZeneca Business Overview
  40. 6.7.3 AstraZeneca TIGIT Therapies Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 AstraZeneca TIGIT Therapies Product Portfolio
  42. 6.7.5 AstraZeneca Recent Developments
  43. 6.8 BeiGene
  44. 6.8.1 BeiGene Company Information
  45. 6.8.2 BeiGene Business Overview
  46. 6.8.3 BeiGene TIGIT Therapies Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 BeiGene TIGIT Therapies Product Portfolio
  48. 6.8.5 BeiGene Recent Developments
  49. 6.9 Hengrui Medicine
  50. 6.9.1 Hengrui Medicine Company Information
  51. 6.9.2 Hengrui Medicine Business Overview
  52. 6.9.3 Hengrui Medicine TIGIT Therapies Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Hengrui Medicine TIGIT Therapies Product Portfolio
  54. 6.9.5 Hengrui Medicine Recent Developments
  55. 6.10 Junshi Biosciences
  56. 6.10.1 Junshi Biosciences Company Information
  57. 6.10.2 Junshi Biosciences Business Overview
  58. 6.10.3 Junshi Biosciences TIGIT Therapies Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Junshi Biosciences TIGIT Therapies Product Portfolio
  60. 6.10.5 Junshi Biosciences Recent Developments
  61. 6.11 Roche
  62. 6.11.1 Roche Company Information
  63. 6.11.2 Roche Business Overview
  64. 6.11.3 Roche TIGIT Therapies Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Roche TIGIT Therapies Product Portfolio
  66. 6.11.5 Roche Recent Developments
  67. 6.12 Merck
  68. 6.12.1 Merck Company Information
  69. 6.12.2 Merck Business Overview
  70. 6.12.3 Merck TIGIT Therapies Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Merck TIGIT Therapies Product Portfolio
  72. 6.12.5 Merck Recent Developments
  73. 6.13 Innovent Biologics
  74. 6.13.1 Innovent Biologics Company Information
  75. 6.13.2 Innovent Biologics Business Overview
  76. 6.13.3 Innovent Biologics TIGIT Therapies Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Innovent Biologics TIGIT Therapies Product Portfolio
  78. 6.13.5 Innovent Biologics Recent Developments
7 North America
  1. 7.1 North America TIGIT Therapies Market Size (2021-2032)
  2. 7.2 North America TIGIT Therapies Market Size by Type
  3. 7.2.1 North America TIGIT Therapies Market Size by Type (2021-2026)
  4. 7.2.2 North America TIGIT Therapies Market Size by Type (2027-2032)
  5. 7.2.3 North America TIGIT Therapies Market Share by Type (2021-2032)
  6. 7.3 North America TIGIT Therapies Market Size by Application
  7. 7.3.1 North America TIGIT Therapies Market Size by Application (2021-2026)
  8. 7.3.2 North America TIGIT Therapies Market Size by Application (2027-2032)
  9. 7.3.3 North America TIGIT Therapies Market Share by Application (2021-2032)
  10. 7.4 North America TIGIT Therapies Market Size by Country
  11. 7.4.1 North America TIGIT Therapies Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America TIGIT Therapies Market Size by Country (2021-2026)
  13. 7.4.3 North America TIGIT Therapies Market Size by Country (2027-2032)
  14. 7.4.4 North America TIGIT Therapies Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe TIGIT Therapies Market Size (2021-2032)
  2. 8.2 Europe TIGIT Therapies Market Size by Type
  3. 8.2.1 Europe TIGIT Therapies Market Size by Type (2021-2026)
  4. 8.2.2 Europe TIGIT Therapies Market Size by Type (2027-2032)
  5. 8.2.3 Europe TIGIT Therapies Market Share by Type (2021-2032)
  6. 8.3 Europe TIGIT Therapies Market Size by Application
  7. 8.3.1 Europe TIGIT Therapies Market Size by Application (2021-2026)
  8. 8.3.2 Europe TIGIT Therapies Market Size by Application (2027-2032)
  9. 8.3.3 Europe TIGIT Therapies Market Share by Application (2021-2032)
  10. 8.4 Europe TIGIT Therapies Market Size by Country
  11. 8.4.1 Europe TIGIT Therapies Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe TIGIT Therapies Market Size by Country (2021-2026)
  13. 8.4.3 Europe TIGIT Therapies Market Size by Country (2027-2032)
  14. 8.4.4 Europe TIGIT Therapies Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China TIGIT Therapies Market Size (2021-2032)
  2. 9.2 China TIGIT Therapies Market Size by Type
  3. 9.2.1 China TIGIT Therapies Market Size by Type (2021-2026)
  4. 9.2.2 China TIGIT Therapies Market Size by Type (2027-2032)
  5. 9.2.3 China TIGIT Therapies Market Share by Type (2021-2032)
  6. 9.3 China TIGIT Therapies Market Size by Application
  7. 9.3.1 China TIGIT Therapies Market Size by Application (2021-2026)
  8. 9.3.2 China TIGIT Therapies Market Size by Application (2027-2032)
  9. 9.3.3 China TIGIT Therapies Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia TIGIT Therapies Market Size (2021-2032)
  2. 10.2 Asia TIGIT Therapies Market Size by Type
  3. 10.2.1 Asia TIGIT Therapies Market Size by Type (2021-2026)
  4. 10.2.2 Asia TIGIT Therapies Market Size by Type (2027-2032)
  5. 10.2.3 Asia TIGIT Therapies Market Share by Type (2021-2032)
  6. 10.3 Asia TIGIT Therapies Market Size by Application
  7. 10.3.1 Asia TIGIT Therapies Market Size by Application (2021-2026)
  8. 10.3.2 Asia TIGIT Therapies Market Size by Application (2027-2032)
  9. 10.3.3 Asia TIGIT Therapies Market Share by Application (2021-2032)
  10. 10.4 Asia TIGIT Therapies Market Size by Country
  11. 10.4.1 Asia TIGIT Therapies Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia TIGIT Therapies Market Size by Country (2021-2026)
  13. 10.4.3 Asia TIGIT Therapies Market Size by Country (2027-2032)
  14. 10.4.4 Asia TIGIT Therapies Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa TIGIT Therapies Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa TIGIT Therapies Market Size by Type
  3. 11.2.1 South America, Middle East & Africa TIGIT Therapies Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa TIGIT Therapies Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa TIGIT Therapies Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa TIGIT Therapies Market Size by Application
  7. 11.3.1 South America, Middle East & Africa TIGIT Therapies Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa TIGIT Therapies Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa TIGIT Therapies Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa TIGIT Therapies Market Size by Country
  11. 11.4.1 South America, Middle East & Africa TIGIT Therapies Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa TIGIT Therapies Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa TIGIT Therapies Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa TIGIT Therapies Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst